Novartis Pharma CEO Is Jimenez; Reorg Entails Layoffs, New Biologics Unit

Novartis is swapping its pharmaceutical and consumer health division heads, making Joe Jimenez the CEO in charge of growing the company's pharmaceutical business

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet